SUGT1P4-STRA6LP

Across TCGA pan-cancer cohorts, SUGT1P4-STRA6LP RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated SUGT1P4-STRA6LP data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SUGT1P4-STRA6LP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SUGT1P4-STRA6LP expression acts as an unfavorable survival marker, although some lineages such as PAAD and READ show a favorable association.

UCEC, PAAD, and LGG are the cancer types where SUGT1P4-STRA6LP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.771	0.867	.001	64	view →
PAAD	DFS	Tertile	All	0.414	0.167	<.001	58	view →
LGG	DFS	Median	All	0.629	0.834	<.001	54	view →
HNSC	OS	Median	All	0.453	0.733	<.001	44	view →
KIRC	DFS	Median	IV	0.453	0.790	.002	37	view →
KICH	DFS	Tertile	III,IV	0.361	0.931	.021	36	view →
LIHC	DFS	Median	II,III,IV	0.266	0.526	<.001	30	view →
GBM	OS	Median	All	0.209	0.328	.004	27	view →
PRAD	OS	Tertile	All	0.619	0.899	<.001	22	view →
READ	OS	Tertile	All	0.845	0.519	.010	20	view →
LUAD	DFS	Quartile	III,IV	0.644	0.177	.005	19	view →
CESC	DFS	Median	IV	0.472	0.090	.012	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

SUGT1P4-STRA6LP–UCEC (DFS)

Open the UCEC breakdown →